{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35649148", "DateCompleted": {"Year": "2022", "Month": "06", "Day": "03"}, "DateRevised": {"Year": "2023", "Month": "02", "Day": "17"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "12", "Day": "15"}], "Language": ["eng"], "ELocationID": ["10.38212/2224-6614.3380"], "Journal": {"ISSN": "2224-6614", "JournalIssue": {"Volume": "29", "Issue": "4", "PubDate": {"Year": "2021", "Month": "Dec", "Day": "15"}}, "Title": "Journal of food and drug analysis", "ISOAbbreviation": "J Food Drug Anal"}, "ArticleTitle": "In-silico efficacy of potential phytomolecules from Ayurvedic herbs as an adjuvant therapy in management of COVID-19.", "Pagination": {"StartPage": "559", "EndPage": "580", "MedlinePgn": "559-580"}, "Abstract": {"AbstractText": ["The recent COVID-19 outbreak caused by SARS-CoV-2 virus has sparked a new spectrum of investigations, research and studies in multifarious directions. Efforts are being made around the world for discovery of effective vaccines/drugs against COVID-19. In this context, Ayurveda, an alternative traditional system of medicine in India may work as an adjuvant therapy in compromised patients. We selected 40 herbal leads on the basis of their traditional applications. The phytomolecules from these leads were further screened through in-silico molecular docking against two main targets of SARS-CoV-2 i.e. the spike protein (S; structural protein) and the main protease (M<sup>PRO</sup>; non-structural protein). Out of the selected 40, 12 phytomolecules were able to block or stabilize the major functional sites of the main protease and spike protein. Among these, Ginsenoside, Glycyrrhizic acid, Hespiridin and Tribulosin exhibited high binding energy with both main protease and spike protein. Etoposide showed good binding energy only with Spike protein and Teniposide had high binding energy only with main protease. The above phytocompounds showed promising binding efficiency with target proteins indicating their possible applications against SARS-CoV-2. However, these findings need to be validated through in vitro and in vivo experiments with above mentioned potential molecules as candidate drugs for the management of COVID-19. In addition, there is an opportunity for the development of formulations through different permutations and combinations of these phytomolecules to harness their synergistic potential."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmacognosy Division, CSIR-National Botanical Research Institute, Lucknow, U.P. 226001, India."}], "LastName": "Kumar", "ForeName": "Bhanu", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmacognosy Division, CSIR-National Botanical Research Institute, Lucknow, U.P. 226001, India."}], "LastName": "Misra", "ForeName": "Ankita", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmacognosy Division, CSIR-National Botanical Research Institute, Lucknow, U.P. 226001, India."}], "LastName": "Singh", "ForeName": "Satyendra Pratap", "Initials": "SP"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Bioinformatics Division, CSIR-National Botanical Research Institute, Lucknow, U.P. 226001, India."}], "LastName": "Dhar", "ForeName": "Yogeshwar Vikram", "Initials": "YV"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmacognosy Division, CSIR-National Botanical Research Institute, Lucknow, U.P. 226001, India."}], "LastName": "Rawat", "ForeName": "Poonam", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "National Institute of Traditional Medicine, Belagavi, Karnataka 590010, India."}], "LastName": "Chattopadhyay", "ForeName": "Debprasad", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmacognosy Division, CSIR-National Botanical Research Institute, Lucknow, U.P. 226001, India."}], "LastName": "Barik", "ForeName": "Saroj Kanta", "Initials": "SK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmacognosy Division, CSIR-National Botanical Research Institute, Lucknow, U.P. 226001, India."}], "LastName": "Srivastava", "ForeName": "Sharad", "Initials": "S"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "China (Republic : 1949- )", "MedlineTA": "J Food Drug Anal", "NlmUniqueID": "101630927"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Plant Preparations"}, {"RegistryNumber": "0", "NameOfSubstance": "Spike Glycoprotein, Coronavirus"}, {"RegistryNumber": "0", "NameOfSubstance": "spike protein, SARS-CoV-2"}, {"RegistryNumber": "EC 3.4.22.-", "NameOfSubstance": "3C-like proteinase, SARS-CoV-2"}, {"RegistryNumber": "EC 3.4.22.28", "NameOfSubstance": "Coronavirus 3C Proteases"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Coronavirus 3C Proteases"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Medicine, Ayurvedic"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Plant Preparations"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["drug effects"], "DescriptorName": "SARS-CoV-2"}, {"QualifierName": [], "DescriptorName": "Spike Glycoprotein, Coronavirus"}, {"QualifierName": [], "DescriptorName": "COVID-19 Drug Treatment"}], "CoiStatement": "\n<b>Declaration of competing interest</b>\n. The authors declare that they have no competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270\u20133.", "ArticleIdList": ["PMC7095418", "32015507"]}, {"Citation": "De Wit E, Van Doremalen N, Falzarano D, Munster VJ. SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol. 2016;14(8):523.", "ArticleIdList": ["PMC7097822", "27344959"]}, {"Citation": "Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus\u2013infected pneumonia. New Engl J Med. 2020;382(13):1199\u2013207.", "ArticleIdList": ["PMC7121484", "31995857"]}, {"Citation": "Jordan PC, Stevens SK, Deval J. Nucleosides for the treatment of respiratory RNA virus infections. Antiviral Chem Chemother. 2018;26:2040206618764483.", "ArticleIdList": ["PMC5890544", "29562753"]}, {"Citation": "Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H, et al. First case of 2019 novel coronavirus in the United States. New Engl J Med. 2020", "ArticleIdList": ["PMC7092802", "32004427"]}, {"Citation": "Rathi S, Ish P, Kalantri A, Kalantri S. Hydroxychloroquine prophylaxis for COVID-19 contacts in India. Lancet Infect Dis. 2020;20(10):1118\u20139.", "ArticleIdList": ["PMC7164849", "32311324"]}, {"Citation": "World Health Organization. Informal consultation on the potential role of chloroquine in the clinical management of COVID 19 infection; Geneva, Switzerland; Mar 13, 2020."}, {"Citation": "Bhinde S. Rasayana: a better alternative for disease prevention. J Ayurveda Holistic Med. 2013;1:6\u201314."}, {"Citation": "Acharya YT, Charaka Samhita, editors. 3/6. Ch. Vi. Varanasi: Chowkhamba Surbharati; 2000."}, {"Citation": "Samal J. Fundamental tenets of epidemiology in Ayurveda and their contemporary relevance. IJHMS. 2016;9(1):20."}, {"Citation": "Basak A, Cooper S, Roberge AG, Banik UK, Chretien M, Seidah NG. Inhibition of proprotein convertases-1,-7 and furin by diterpines of Andrographis paniculata and their succinoyl esters. Biochem J. 1999;338:107\u201313.", "ArticleIdList": ["PMC1220031", "9931305"]}, {"Citation": "Majumdar S, Mohanta BC, Chowdhury DR, Banik R, Dinda B, Basak A. Proprotein convertase inhibitory activities of flavonoids isolated from Oroxylum indicum. Curr Med Chem. 2010;17(19):2049\u201358.", "ArticleIdList": ["20423311"]}, {"Citation": "Pel P, Chae HS, Nhoek P, Kim YM, Chin YW. Chemical constituents with proprotein convertase subtilisin/kexin type 9 mRNA expression inhibitory activity from dried immature Morus alba fruits. J Agr Food Chem. 2017;65(26):5316\u201321.", "ArticleIdList": ["28649844"]}, {"Citation": "Muthuramalingam P, Jeyasri R, Valliammai A, Selvaraj A, Karthika C, Gowrishankar S, et al. Global multi-omics and systems pharmacological strategy unravel the multi-targeted therapeutic potential of natural bioactive molecules against COVID-19: An in silico approach. Genomics. 2020;112(6):4486\u2013504.", "ArticleIdList": ["PMC7410791", "32771622"]}, {"Citation": "Mehany T, Khalifa I, Barakat H, Althwab SA, Alharbi YM, El-Sohaimy S. Polyphenols as promising biologically active substances for preventing SARS-CoV-2: a review with research evidence and underlying mechanisms. Food Biosci. 2021:100891.", "ArticleIdList": ["PMC7817466", "33495727"]}, {"Citation": "Khalifa I, Nawaz A, Sobhy R, Althwab SA, Barakat H. Polyacylated anthocyanins constructively network with catalytic dyad residues of 3CLpro of 2019-nCoV than monomeric anthocyanins: a structural-relationship activity study with 10 anthocyanins using in-silico approaches. J Mol Graph Model. 2020;100:107690.", "ArticleIdList": ["PMC7380243", "32745925"]}, {"Citation": "Khalifa I, Zhu W, Mohammed HH, Dutta K, Li C. Tannins inhibit SARS-CoV-2 through binding with catalytic dyad residues of 3CLpro: an in silico approach with 19 structural different hydrolysable tannins. J Food Biochem. 2020;44(10):e13432.", "ArticleIdList": ["PMC7435556", "32783247"]}, {"Citation": "Hassan ST, Masar\u010d\u00edkov\u00e1 R, Berchov\u00e1 K. Bioactive natural products with anti-herpes simplex virus properties. J Pharm Pharmaco. 2015;67(10):1325\u201336.", "ArticleIdList": ["26060043"]}, {"Citation": "Mukherjee H, Ojha D, Bag P, Chandel HS, Bhattacharyya S, Chatterjee TK, et al. Anti-herpes virus activities of Achyranthes aspera: an Indian ethnomedicine, and its triterpene acid. Microbiol Res. 2013;168(4):238\u201344.", "ArticleIdList": ["23218996"]}, {"Citation": "Cheng HY, Yang CM, Lin TC, Lin LT, Chiang LC, Lin CC. Excoecarianin, isolated from Phyllanthus urinaria Linnea, inhibits herpes simplex virus type 2 infection through inactivation of viral particles. Evid-Based Complementary Altern Med. 2011;2011:259103.", "ArticleIdList": ["PMC3136347", "19808846"]}, {"Citation": "Gescher K, K\u00fchn J, Hafezi W, Louis A, Derksen A, Deters A, et al. Inhibition of viral adsorption and penetration by an aqueous extract from Rhododendron ferrugineum L. as antiviral principle against herpes simplex virus type-1. Fitoterapia. 2011;82(3):408\u201313.", "ArticleIdList": ["21129454"]}, {"Citation": "Lim YX, Ng YL, Tam JP, Liu DX. Human coronaviruses: a review of virus\u2013host interactions. Diseases. 2016;4(3):26.", "ArticleIdList": ["PMC5456285", "28933406"]}, {"Citation": "Bertol JW, Rigotto C, de P\u00e1dua RM, Kreis W, Barardi CRM, Braga FC, et al. Antiherpes activity of glucoevatromonoside, a cardenolide isolated from a Brazilian cultivar of Digitalis lanata. Antiviral Res. 2011;92:73\u201380.", "ArticleIdList": ["21763352"]}, {"Citation": "Ikeda K, Tsujimoto K, Uozaki M, Nishide M, Suzuki Y, Koyama AH, et al. Inhibition of multiplication of herpes simplex virus by caffeic acid. Int JMol Med. 2011;28(4):595\u20138.", "ArticleIdList": ["21725588"]}, {"Citation": "Yarmolinsky L, Zaccai M, Ben-Shabat S, Mills D, Huleihel M. Antiviral activity of ethanol extracts of Ficus Binjamina and Lilium candidum in vitro. N Biotechnol. 2009;26(6):307\u201313.", "ArticleIdList": ["19703599"]}, {"Citation": "Chin LW, Cheng YW, Lin SS, Lai YY, Lin LY, Chou MY, et al. Anti-herpes simplex virus effects of berberine from Coptidis rhizoma, a major component of a Chinese herbal medicine, Ching-Wei-San. Arch Virol. 2010;155(12):1933\u201341.", "ArticleIdList": ["20686799"]}, {"Citation": "Bag P, Ojha D, Mukherjee H, Halder UC, Mondal S, Biswas A, et al. A dihydro-pyrido-indole potently inhibits HSV-1 infection by interfering the viral immediate early transcriptional events. Antiviral Res. 2014;105:126\u201334.", "ArticleIdList": ["24576908"]}, {"Citation": "Bag P, Ojha D, Mukherjee H, Halder UC, Mondal S, Chandra NS, et al. An indole alkaloid from a tribal folklore inhibits immediate early event in HSV-2 infected cells with therapeutic efficacy in vaginally infected mice. PLoS One. 2013;8:77937.", "ArticleIdList": ["PMC3805518", "24167591"]}, {"Citation": "Khanal P, Duyu T, Dey YN, Patil BM, Pasha I, Wanjari M.Network pharmacology of AYUSH recommended immune-boosting medicinal plants against COVID-19. 2020.", "ArticleIdList": ["PMC7687402", "33250601"]}, {"Citation": "Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol. 2003;3(2):133\u201346.", "ArticleIdList": ["12563297"]}, {"Citation": "D\u2019Alessandro S, Scaccabarozzi D, Signorini L, Perego F, Ilboudo DP, Ferrante P, et al. The use of antimalarial drugs against viral infection. Microorganisms. 2020;8(1):85.", "ArticleIdList": ["PMC7022795", "31936284"]}, {"Citation": "Wu C, Liu Y, Yang Y, Zhang P, Zhong W, Wang Y, et al. Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharm Sin B. 2020;10(5):766\u201388.", "ArticleIdList": ["PMC7102550", "32292689"]}, {"Citation": "Liu X, Wang XJ. Potential inhibitors against 2019-nCoV coronavirus M protease from clinically approved medicines. J Gent Genomics. 2020;47(2):119.", "ArticleIdList": ["PMC7128649", "32173287"]}, {"Citation": "Wallace AC, Laskowski RA, Thornton JM. LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Protein Eng Des Sel. 1995;8(2):127\u201334.", "ArticleIdList": ["7630882"]}, {"Citation": "Gil C, Ginex T, Maestro I, Nozal V, Barrado-Gil L, Cuesta-Geijo MA, et al. COVID-19: drug targets and potential treatments. J Med Chem. 2020;63(21):12359\u201386.", "ArticleIdList": ["32511912"]}, {"Citation": "Narkhede RR, Pise AV, Cheke RS, Shinde SD. Recognition of natural products as potential inhibitors of COVID-19 main protease (Mpro): in-silico evidences. Nat Prod Bio-prospect. 2020;10(5):297\u2013306.", "ArticleIdList": ["PMC7299459", "32557405"]}, {"Citation": "Chan JF, Kok KH, Zhu Z, Chu H, To KK, Yuan S, et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect. 2020;9:221\u201336.", "ArticleIdList": ["PMC7067204", "31987001"]}, {"Citation": "Chen L, Liu W, Zhang Q, Xu K, Ye G, Wu W, et al. RNA based mNGS approach identifies a novel human coronavirus from two individual pneumonia cases in 2019 Wuhan outbreak. Emerg Microbes Infect. 2020;9:313\u20139.", "ArticleIdList": ["PMC7033720", "32020836"]}, {"Citation": "Lu Q, Shi Y. Coronavirus disease (COVID-19) and neonate: what neonatologist need to know. J Med Virol. 2020;92(6):564\u20137.", "ArticleIdList": ["PMC7228398", "32115733"]}, {"Citation": "Wang H, Li K, Ma L, Wu S, Hu J, Yan H, et al. Berberine inhibits enterovirus 71 replication by downregulating the MEK/ERK signaling pathway and autophagy. Virol J. 2017;14(1):2.", "ArticleIdList": ["PMC5234143", "28081706"]}, {"Citation": "Prasad A, Muthamilarasan M, Prasad M. Synergistic antiviral effects against SARS-CoV-2 by plant-based molecules. Plant cell rep. 2020;39(9):1109\u201314.", "ArticleIdList": ["PMC7303273", "32561979"]}, {"Citation": "Misra A, Mishra P, Kumar B, Shukla PK, Kumar M, Singh SP, et al. Intra-specific molecular and chemical variabilities in natural populations of Gloriosa superba (L.,) for identifying elite chemotypes for commercial utilization. Fitoterapia. 2021;150:104831.", "ArticleIdList": ["33545298"]}, {"Citation": "Misra A, Srivastava S, Kumar S, Shukla PK, Kumar M, Agrawal PK, et al. Chemotaxonomic studies on natural population of Gloriosa superba (L.) collected from Gangetic plain (India) and their in vitro antigout activity for the identification of elite germplasm(s) J Ethnopharmacol. 2020;249:112387.", "ArticleIdList": ["31756449"]}, {"Citation": "Kar P, Sharma NR, Singh B, Sen A, Roy A. Natural compounds from Clerodendrum spp. as possible therapeutic candidates against SARS-CoV-2: an in-silico investigation. J Biomol Struct Dyn. 2020;18:1\u20132.", "ArticleIdList": ["PMC7309333", "32552595"]}, {"Citation": "Naik B, Gupta N, Ojha R, Singh S, Prajapati VK, Prusty D. High throughput virtual screening reveals SARS-CoV-2 multi-target binding natural compounds to lead instant therapy for COVID-19 treatment. Int J Biol Macromol. 2020;160:1\u201317.", "ArticleIdList": ["PMC7250083", "32470577"]}, {"Citation": "Shawky E, Nada AA, Ibrahim RS. Potential role of medicinal plants and their constituents in the mitigation of SARS-CoV-2: identifying related therapeutic targets using network pharmacology and molecular docking analyses. RSC Adv. 2020;10(47):27961\u201383.", "ArticleIdList": ["PMC9055652", "35519104"]}, {"Citation": "Zhang DH, Wu KL, Zhang X, Deng SQ, Peng B. In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus. J Integr Med. 2020;18(2):152\u20138.", "ArticleIdList": ["PMC7102521", "32113846"]}, {"Citation": "Bosch BJ, van der Zee R, de Haan CA, Rottier PJ. The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex. J Virol. 2003;77:8801\u201311.", "ArticleIdList": ["PMC167208", "12885899"]}, {"Citation": "Du QS, Wang SQ, Zhu Y, Wei DQ, Guo H, Sirois S, et al. Polyprotein cleavage mechanism of SARS CoV Mpro and chemical modification of the octapeptide. Peptides. 2004;25(11):1857\u201364.", "ArticleIdList": ["PMC7115412", "15501516"]}, {"Citation": "Ullrich S, Nitsche C. The SARS-CoV-2 main protease as drug target. Bioorg Med Chem Lett. 2020;30(17):127377.", "ArticleIdList": ["PMC7331567", "32738988"]}, {"Citation": "Huang J, Peng K, Wang L, Wen B, Zhou L, Luo T, et al. Ginsenoside Rh2 inhibits proliferation and induces apoptosis in human leukemia cells via TNF-\u03b1 signaling pathway. Acta Biochim Biophys Sin. 2016;48(8):750\u20135.", "ArticleIdList": ["27177748"]}, {"Citation": "Joshi RS, Jagdale SS, Bansode SB, Shankar SS, Tellis MB, Pandya VK, et al. Discovery of potential multi-target-directed ligands by targeting host-specific SARS-CoV-2 structurally conserved main protease. J Biomol Struct Dyn. 2020;5:1\u20136.", "ArticleIdList": ["PMC7212545", "32329408"]}, {"Citation": "Islam MT, Sarkar C, El Kersh DM, Jamaddar S, Uddin SJ, Shilpi JA, et al. Natural products and their derivatives against coronavirus: a review of the non-clinical and pre-clinical data. Phytoth Res. 2020:1\u201322.", "ArticleIdList": ["32248575"]}, {"Citation": "Cinatl J, Morgenstern B, Bauer G, Chandra P, Rabenau H, Doerr HW. Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. The Lancet. 2003;361(9374):2045\u20136.", "ArticleIdList": ["PMC7112442", "12814717"]}, {"Citation": "Ming LJ, Yin AC. Therapeutic effects of glycyrrhizic acid. Nat Pro Commun. 2013;8(3) 1934578X1300800335.", "ArticleIdList": ["23678825"]}, {"Citation": "Chia YY, Ton SH, Khalid BAK. Effects of glycyrrhizic acid on peroxime proliferator-activated receptor gamma (PPAR-\u03b3), lipoprotein lipase (LPL), serum lipid and HOMA-IR in rats. PPAR Res. 2009;6:125\u201341.", "ArticleIdList": ["PMC2786009", "20011054"]}, {"Citation": "Li SY, Chen C, Zhang HQ, Guo HY, Wang H, Wang L, et al. Identification of natural compounds with antiviral activities against SARS-associated coronavirus. Antivir Res. 2005;67(1):18\u201323.", "ArticleIdList": ["PMC7114104", "15885816"]}, {"Citation": "Wu CY, Jan JT, Ma SH, Kuo CJ, Juan HF, Cheng YS. Small molecules targeting severe acute respiratory syndrome human coronavirus. Proc Natl Acad Sci U S A. 2004;101:10012\u20137.", "ArticleIdList": ["PMC454157", "15226499"]}, {"Citation": "Lee WK, Kao ST, Liu IM, Cheng JT. Ginsenoside Rh2 is one of the active principles of Panax ginseng root to improve insulin sensitivity in fructose-rich chow-fed rats. Hor Metab Res. 2007;39(5):347\u201354.", "ArticleIdList": ["17533576"]}, {"Citation": "Mathiyalagan R, Wang C, Kim YJ, Castro-Aceituno V, Ahn S, Subramaniyam S, et al. Preparation of polyethylene glycol-ginsenoside Rh1 and Rh2 conjugates and their efficacy against lung cancer and inflammation. Molecules. 2019;24(23):4367.", "ArticleIdList": ["PMC6930446", "31795352"]}, {"Citation": "Wang H, Yu P, Gou H, Zhang J, Zhu M, Wang ZH, et al. Cardioprotective effects of 20 (S)-ginsenoside Rh2 against doxorubicin-induced cardiotoxicity in vitro and in vivo. Evid Based Complementary Altern Med. 2012:506214.", "ArticleIdList": ["PMC3483725", "23125868"]}, {"Citation": "World Health Organization. World Health Organization model list of essential medicines: 21st list 2019 (No. WHO/ MVP/EMP/IAU/2019.06)"}, {"Citation": "Ganeshpurkar A, Saluja AK. The pharmacological potential of rutin. Saudi Pharm J Saudi. 2017;25(2):149\u201364.", "ArticleIdList": ["PMC5355559", "28344465"]}, {"Citation": "Chiow KH, Phoon MC, Putti T, Tan BK, Chow VT. Evaluation of antiviral activities of Houttuynia cordata Thunb. extract, quercetin, quercetrin and cinanserin on murine coronavirus and dengue virus infection. Asian Pac J Trop Med. 2016;9(1):1\u20137.", "ArticleIdList": ["PMC7104935", "26851778"]}, {"Citation": "Hu X, Cai X, Song X, Li C, Zhao J, Luo W, et al. Possible SARS-coronavirus 2 inhibitor revealed by simulated molecular docking to viral main protease and host toll-like receptor. Future Virol. 2020"}, {"Citation": "Perricone C, Triggianese P, Bartoloni E, Cafaro G, Bonifacio AF, Bursi R, et al. The anti-viral facet of anti-rheumatic drugs: lessons from COVID-19. J Autoimmun. 2020:102468.", "ArticleIdList": ["PMC7164894", "32317220"]}, {"Citation": "Martinon F, P\u00e9trilli V, Mayor A, Tardivel A, Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature. 2006;440(7081):237\u201341.", "ArticleIdList": ["16407889"]}, {"Citation": "Slobodnick A, Shah B, Krasnokutsky S, Pillinger MH. Update on colchicine, 2017. Rheumatology. 2018;57(suppl_1):i4\u201311.", "ArticleIdList": ["PMC5850858", "29272515"]}, {"Citation": "Haggag YA, El-Ashmawy NE, Okasha KM. Is hesperidin essential for prophylaxis and treatment of COVID-19 Infection? Me Hypotheses. 2020:109957.", "ArticleIdList": ["PMC7274964", "32531538"]}, {"Citation": "Semerdjieva IB, Zheljazkov VD. Chemical constituents, biological properties, and uses of Tribulus terrestris: a review. Nat Prod Commun. 2019;14(8) 1934578X19868394."}, {"Citation": "Kostova I, Dinchev D. Saponins in Tribulus terrestris\u2013chemistry and bioactivity. Phytochem Rev. 2005;4(2\u20133):111\u201337."}, {"Citation": "He X, Xiang N, Zhang J, Zhou J, Fu Y, Gong T, et al. Encapsulation of teniposide into albumin nanoparticles with greatly lowered toxicity and enhanced antitumor activity. Int J Pharm. 2015;487(1\u20132):250\u20139.", "ArticleIdList": ["25899285"]}, {"Citation": "Zhang J, Chen Y, Luo H, Sun L, Xu M, Yu J, et al. Recent update on the pharmacological effects and mechanisms of dihydromyricetin. Front Pharmacol. 2018;9:1204.", "ArticleIdList": ["PMC6209623", "30410442"]}, {"Citation": "Kim HS, Lee EH, Ko SR, Choi KJ, Park JH, Im DS. Effects of ginsenosides Rg3 and Rh2 on the proliferation of prostate cancer cells. Arch Pharma Res. 2004;27(4):429.", "ArticleIdList": ["15180309"]}, {"Citation": "Shi J, Cao B, Zha WB, Wu XL, Liu LS, Xiao WJ, et al. Pharmacokinetic interactions between 20 (S)-ginsenoside Rh2 and the HIV protease inhibitor ritonavir in vitro and in vivo. Acta Pharmacol Sin. 2013;34(10):1349.", "ArticleIdList": ["PMC4002158", "23892274"]}, {"Citation": "Kang S, Im K, Kim G, Min H. Antiviral activity of 20 (R)-ginsenoside Rh2 against murine gammaherpesvirus. J Ginseng Res. 2017;41(4):496\u2013502.", "ArticleIdList": ["PMC5628367", "29021696"]}, {"Citation": "Nakata H, Kikuchi Y, Tode T, Hirata J, Kita T, Ishii K, et al. Inhibitory effects of ginsenoside Rh2 on tumor growth in nude mice bearing human ovarian cancer cells. Jpn J Cancer Res. 1998;89(7):733\u201340.", "ArticleIdList": ["PMC5921889", "9738980"]}, {"Citation": "Cao M, Zhang J, Zhao Y, Song X, Ma B. Advances in ginsenoside Rh2 and its derivatives. World Sci Technol. 2012;14:2205\u201311."}, {"Citation": "Wang W, Zhao Y, Rayburn ER, Hill DL, Wang H, Zhang R. In vitro anti-cancer activity and structure\u2013activity relationships of natural products isolated from fruits of Panax ginseng. Cancer Chemother Pharmacol. 2007;59(5):589\u2013601.", "ArticleIdList": ["16924497"]}, {"Citation": "Qian T, Cai Z. Biotransformation of ginsenosides Rb1, Rg3 and Rh2 in rat gastrointestinal tracts. Chi Med. 2010;5(1):19.", "ArticleIdList": ["PMC2887866", "20504301"]}, {"Citation": "Qian T, Cai Z, Wong RN, Jiang ZH. Liquid chromatography/ mass spectrometric analysis of rat samples for in vivo metabolism and pharmacokinetic studies of ginsenoside Rh2. Rapid Commun Mass Spectr: Int J Dev Rapid Disseminat Res Mass Spectro. 2005;19(23):3549\u201354.", "ArticleIdList": ["16261639"]}, {"Citation": "Carabin IG, Burdock GA, Chatzidakis C. Safety assessment of Panax ginseng. Int J Toxicol. 2000;19:293\u2013301."}, {"Citation": "Park SJ, Lim KH, Noh JH, Jeong EJ, Kim YS, Han BC, et al. Subacute oral toxicity study of Korean red ginseng extract in Sprague-Dawley rats. Toxicol Res. 2013;29(4):285\u201392.", "ArticleIdList": ["PMC3936181", "24578799"]}, {"Citation": "Li JY, Cao HY, Liu P, Cheng GH, Sun MY. Glycyrrhizic acid in the treatment of liver diseases: literature review. BioMed Res Int. 2014:2014.", "ArticleIdList": ["PMC4052927", "24963489"]}, {"Citation": "Hoever G, Baltina L, Michaelis M, Kondratenko R, Baltina L, Tolstikov GA, et al. Antiviral activity of glycyrrhizic acid derivatives against SARS-coronavirus. J Med Chem. 2005;48:1256\u20139.", "ArticleIdList": ["15715493"]}, {"Citation": "Fukuchi K, Okudaira N, Adachi K, Odai-Ide R, Watanabe S, Ohno H, et al. Antiviral and antitumor activity of licorice root extracts. In Vivo. 2016;30(6):777\u201385.", "ArticleIdList": ["27815461"]}, {"Citation": "Wang L, Yang R, Yuan B, Liu Y, Liu C. The antiviral and antimicrobial activities of licorice, a widely-used Chinese herb. Acta Pharm Sin B. 2015;5(4):310\u20135.", "ArticleIdList": ["PMC4629407", "26579460"]}, {"Citation": "Yeh CF, Wang KC, Chiang LC, Shieh DE, Yen MH, San Chang J. Water extract of licorice had anti-viral activity against human respiratory syncytial virus in human respiratory tract cell lines. J Ethnopharmacol. 2018;148(2):466\u201373.", "ArticleIdList": ["PMC7126896", "23643542"]}, {"Citation": "Van Gelderen CE, Bijlsma JA, Van Dokkum W, Savelkoull TJ. Glycyrrhizic acid: the assessment of a no effect level. Hum Exp Toxicol. 2000;19(8):434\u20139.", "ArticleIdList": ["11125713"]}, {"Citation": "Johns C. Glycyrrhizic acid toxicity caused by consumption of licorice candy cigars. Can J Emer Med. 2009;11(1):94\u20136.", "ArticleIdList": ["19166646"]}, {"Citation": "Black licorice: trick or treat? US Food and Drug Administration; Oct 30, 2017.  \n https://www.fda.gov/consumers/consumer-updates/black-licorice-trick-or-treat\n."}, {"Citation": "Ferrari P, Sansonnens A, Dick B, Frey FJ. In vivo 11\u03b2-HSD-2 activity: variability, salt-sensitivity, and effect of licorice. Hypertension. 2001;38(6):1330\u20136.", "ArticleIdList": ["11751713"]}, {"Citation": "Penninkilampi R, Eslick EM, Eslick GD. The association between consistent licorice ingestion, hypertension and hypokalaemia: a systematic review and meta-analysis. J Hum Hypertens. 2017;31(11):699\u2013707.", "ArticleIdList": ["28660884"]}, {"Citation": "Choi HJ, Kim JH, Lee CH, Ahn YJ, Song JH, Baek SH, et al. Antiviral activity of quercetin 7-rhamnoside against porcine epidemic diarrhea virus. Antivir Res. 2009;81(1):77\u201381.", "ArticleIdList": ["PMC7114206", "18992773"]}, {"Citation": "Kaul TN, Middleton E, Jr, Ogra PL. Antiviral effect of flavonoids on human viruses. J Med Virol. 1985;15(1):71\u20139.", "ArticleIdList": ["2981979"]}, {"Citation": "Vlietinck AJ, Vanden Berghe DA, Haemers A. Present status and prospects of flavonoids as anti-viral agents. Prog Clin Biol Res. 1988;280:283\u201399.", "ArticleIdList": ["3051028"]}, {"Citation": "Vrijsen R, Everaert L, Boey\u00e9 A. Antiviral activity of flavones and potentiation by ascorbate. J Gen Virol. 1988;69(7):1749\u201351.", "ArticleIdList": ["2839607"]}, {"Citation": "Dabeek WM, Marra MV. Dietary quercetin and kaempferol: bioavailability and potential cardiovascular-related bioactivity in humans. Nutrients. 2019;11(10):2288.", "ArticleIdList": ["PMC6835347", "31557798"]}, {"Citation": "Hollman PC. Absorption, bioavailability, and metabolism of flavonoids. Pharm Biol. 2004;42(sup1):74\u201383."}, {"Citation": "Graefe EU, Wittig J, Mueller S, Riethling AK, Uehleke B, Drewelow B, et al. Pharmacokinetics and bioavailability of quercetin glycosides in humans. J Clin Pharm. 2001;41(5):492\u20139.", "ArticleIdList": ["11361045"]}, {"Citation": "Olthof MR, Hollman PC, Vree TB, Katan MB. Bio-availabilities of quercetin-3-glucoside and quercetin-4\u2032-glucoside do not differ in humans. J Nutr. 2000;130(5):1200\u20133.", "ArticleIdList": ["10801919"]}, {"Citation": "Micronutrient information center. Corvallis, Oregon: Linus Pauling Institute, Oregon State University; Nov, 2015. Flavonoids."}, {"Citation": "Sultana S, Asif HM, Akhtar N, Waqas M, Rehman SU. Comprehensive review on ethanobotanical uses, phytochemistry and pharmacological properties of Melia azedarach linn. AJPRHC. 2014;6(1)"}, {"Citation": "Alche LE, Ferek GA, Meo M, Coto CE, Maier MS. An antiviral meliacarpin from leaves of Melia azedarach L. Zeitschrift f\u00fcr Naturforschung C. 2003;58:215\u20139.", "ArticleIdList": ["12710731"]}, {"Citation": "Barquero AA, Michelini FM, Alche LE. 1-Cinnamoyl-3, 11-dihydroxymeliacarpin is a natural bioactive compound with antiviral and nuclear factor-\u03baB modulating properties. Biochem Biophys Res Commun. 2006;344:955\u201362.", "ArticleIdList": ["16631615"]}, {"Citation": "Petrera E, Coto CE. The synergistic effect of IFN-\u03b1 and IFN-\u03b3 against HSV-2 replication in Vero cells is not interfered by the plant antiviral 1-cinnamoyl-3, 11-dihydroxymeliacarpin. Virol J. 2006;3(1):45.", "ArticleIdList": ["PMC1525181", "16772029"]}, {"Citation": "Nerome K, Shimizu K, Zukeran S, Igarashi Y, Kuroda K, Sugita S, et al. Functional growth inhibition of influenza A and B viruses by liquid and powder components of leaves from the subtropical plant Melia azedarach L. Arch Virol. 2018;163(8):2099\u2013109.", "ArticleIdList": ["PMC6096724", "29633076"]}, {"Citation": "Kim HY, Shin HS, Park H, Kim YC, Yun YG, Park S, et al. In vitro inhibition of coronavirus replications by the traditionally used medicinal herbal extracts, Cimicifuga rhizoma, Meliae cortex, Coptidis rhizoma, and Phellodendron cortex. J Clin Virol. 2008;41(2):122\u20138.", "ArticleIdList": ["PMC7108295", "18036887"]}, {"Citation": "Phua DH, Tsai WJ, Ger J, Deng JF, Yang CC. Human Melia azedarach poisoning. Clin Toxicol. 2008;46(10):1067\u201370.", "ArticleIdList": ["18763152"]}, {"Citation": "Dai P, Wang J, Lin L, Zhang Y, Wang Z. Renoprotective effects of berberine as adjuvant therapy for hypertensive patients with type 2 diabetes mellitus: evaluation via biochemical markers and color Doppler ultrasonography. Exp Ther Med. 2015;10(3):869\u201376.", "ArticleIdList": ["PMC4533140", "26622407"]}, {"Citation": "Domitrovi\u0107 R, Jakovac H, Blagojevi\u0107 G. Hepatoprotective activity of berberine is mediated by inhibition of TNF-\u03b1, COX-2, and iNOS expression in CCl4-intoxicated mice. Toxicol. 2011;280(1\u20132):33\u201343.", "ArticleIdList": ["21095217"]}, {"Citation": "Neag MA, Mocan A, Echeverr\u00eda J, Pop RM, Bocsan CI, Cri\u015fan G, et al. Berberine: Botanical occurrence, traditional uses, extraction methods, and relevance in cardiovascular, metabolic, hepatic, and renal disorders. Front Pharmacol. 2018;9:557.", "ArticleIdList": ["PMC6111450", "30186157"]}, {"Citation": "Fabricant DS, Farnsworth NR. The value of plants used in traditional medicine for drug discovery. Environ Health Perspec. 2001;109(suppl 1):69\u201375.", "ArticleIdList": ["PMC1240543", "11250806"]}, {"Citation": "Feng X, Sureda A, Jafari S, Memariani Z, Tewari D, Annunziata G, et al. Berberine in cardiovascular and metabolic diseases: from mechanisms to therapeutics. Theranostics. 2019;9(7):1923.", "ArticleIdList": ["PMC6485276", "31037148"]}, {"Citation": "Berberine. PubChem, National Library of Medicine, US National Institutes of Health; Mar 9, 2020."}, {"Citation": "Singh IP, Mahajan S. Berberine and its derivatives: a patent review (2009\u20132012) Expert Opin Ther Pat. 2013;23(2):215\u201331.", "ArticleIdList": ["23231038"]}, {"Citation": "Chen C, Yu Z, Li Y, Fichna J, Storr M. Effects of berberine in the gastrointestinal tract- a review of actions and therapeutic implications. Am J Chin Med. 2014;42:1053\u201370.", "ArticleIdList": ["25183302"]}, {"Citation": "Yu C, Tan S, Zhou C, Zhu C, Kang X, Liu S, et al. Berberine reduces uremia-associated intestinal mucosal barrier damage. Biol Pharm Bull. 2016:b16\u2013280.", "ArticleIdList": ["27506986"]}, {"Citation": "Enkhtaivan G, Muthuraman P, Kim DH, Mistry B. Discovery of berberine based derivatives as anti-influenza agent through blocking of neuraminidase. Bioorg Med Chem. 2017;25(20):5185\u201393.", "ArticleIdList": ["28958846"]}, {"Citation": "Batista MN, Braga ACS, Campos GRF, Souza MM, Matos RPAD, Lopes TZ, et al. Natural products isolated from oriental medicinal herbs inactivate zika virus. Viruses. 2019;11:49.", "ArticleIdList": ["PMC6356660", "30641880"]}, {"Citation": "Varghese FS, Thaa B, Amrun SN, Simarmata D, Rausalu K, Nyman TA, et al. The antiviral alkaloid berberine reduces chikungunya virus-induced mitogen-activated protein kinase signaling. J Virol. 2016;90(21):9743\u201357.", "ArticleIdList": ["PMC5068526", "27535052"]}, {"Citation": "Rosa-Calatrava M, Terrier O, Proust A, Moules V. Centre National de la Recherche Scientifique CNRS, Universite Claude Bernard Lyon 1 (UCBL) and Institut National de la Sante et de la Recherche Medicale INSERM, (2019) Antiviral compositions for the treatment of infections linked to coronaviruses. US Patent Appl. 16(340):346."}, {"Citation": "Basha SH. Corona virus drugs\u2013a brief overview of past, present and future. J Peer Sci. 2020;2:1000013."}, {"Citation": "Maurya DK, Sharma D. Evaluation of traditional ayurvedic preparation for prevention and management of the novel Coronavirus (SARS-CoV-2) using molecular docking approach. 2020", "ArticleIdList": ["PMC7754934", "33251972"]}, {"Citation": "Cui HX, Hu YN, Li JW, Yuan K, Guo Y. Preparation and evaluation of antidiabetic agents of berberine organic acid salts for enhancing the bioavailability. Molecules. 2019;24(1):103.", "ArticleIdList": ["PMC6337101", "30597911"]}, {"Citation": "Gupta PK, Gurley BJ, Barone G, Hendrickson HP. Clinical pharmacokinetics and metabolism of berberine and hydrastine following an oral dose of goldenseal supplement. Planta Med. 2010;76(5):P110."}, {"Citation": "Singh N, Sharma B. Toxicological effects of berberine and sanguinarine. Front Mol Biosci. 2018;5:21.", "ArticleIdList": ["PMC5867333", "29616225"]}, {"Citation": "Yin J, Xing H, Ye J. Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism. 2008;57(5):712\u20137.", "ArticleIdList": ["PMC2410097", "18442638"]}, {"Citation": "Grycova L, Dost\u00e1l J, Marek R. Quaternary protoberberine alkaloids. Phytochem. 2007;68(2):150\u201375.", "ArticleIdList": ["17109902"]}, {"Citation": "Marek R, Seck\u00e1\u0159ov\u00e1 P, Hulov\u00e1 D, Marek J, Dost\u00e1l J, Sklen\u00e1\u0159 V. Palmatine and berberine isolation artifacts. J Nat Pro. 2003;66(4):481\u20136.", "ArticleIdList": ["12713397"]}, {"Citation": "Man MQ, Yang B, Elias PM. Benefits of hesperidin for cutaneous functions. Evid-Based Compl Alt. 2019:2019.", "ArticleIdList": ["PMC6466919", "31061668"]}, {"Citation": "Lipson SM, Ozen FS, Louis S, Karthikeyan L. Comparison of \u03b1-glucosyl hesperidin of citrus fruits and epigallocatechin gallate of green tea on the Loss of Rotavirus Infectivity in Cell Culture. Front Microbio. 2015;6:359.", "ArticleIdList": ["PMC4413797", "25972850"]}, {"Citation": "Bino A, Vicentini CB, Vertuani S, Lampronti I, Gambari R, Durini E, et al. Novel lipidized derivatives of the bioflavonoid hesperidin: dermatological, cosmetic and chemo-preventive applications. Cosmetics. 2018;5(4):72."}, {"Citation": "Ding Z, Sun G, Zhu Z. Short communication Hesperidin attenuates influenza A virus (H1N1) induced lung injury in rats through its anti-inflammatory effect. Antivir Ther. 2018;23:611\u20135.", "ArticleIdList": ["29623897"]}, {"Citation": "Dong W, Wei X, Zhang F, Hao J, Huang F, Zhang C, et al. A dual character of flavonoids in influenza A virus replication and spread through modulating cell-autonomous immunity by MAPK signaling pathways. Sci Rep. 2014;4:7237.", "ArticleIdList": ["PMC4246350", "25429875"]}, {"Citation": "Tsai FJ, Lin CW, Lai CC, Lan YC, Lai CH, Hung CH, et al. Kaempferol inhibits enterovirus 71 replication and internal ribosome entry site (IRES) activity through FUBP and HNRP proteins. Food Chem. 2011;128(2):312\u201322.", "ArticleIdList": ["25212137"]}, {"Citation": "Lin CW, Tsai FJ, Tsai CH, Lai CC, Wan L, Ho TY, et al. Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plant-derived phenolic compounds. Antiviral Res. 2005;68(1):36\u201342.", "ArticleIdList": ["PMC7114321", "16115693"]}, {"Citation": "Estruel-Amades S, Massot-Cladera M, P\u00e9rez-Cano FJ, Franch \u00c0, Castell M, Camps-Bossacoma M. Hesperidin effects on gut microbiota and gut-associated lymphoid tissue in healthy rats. Nutrients. 2019;11(2):324.", "ArticleIdList": ["PMC6412496", "30717392"]}, {"Citation": "Nectoux AM, Abe C, Huang SW, Ohno N, Tabata J, Miyata Y, et al. Absorption and metabolic behavior of hesperidin (rutinosylated hesperetin) after single oral administration to Sprague-Dawley rats. J Agr Food Chem. 2019;67(35):9812\u20139.", "ArticleIdList": ["31392887"]}, {"Citation": "Li YM, Li XM, Li GM, Du WC, Zhang J, Li WX, et al. In vivo pharmacokinetics of hesperidin are affected by treatment with glucosidase-like BglA protein isolated from yeasts. J Agri Food Chem. 2008;56(14):5550\u20137.", "ArticleIdList": ["PMC2782632", "18570429"]}, {"Citation": "Moro L, Vasconcelos AC, Martins AS. Etoposide-induced apoptosis in murine neuroblastoma (N2A) cells infected with Paramyxoviruses. Arq Bras Med Vet Zoo. 2003;55(1):44\u201350."}, {"Citation": "Schindler M, M\u00fcnch J, Kirchhoff F. Human immunodeficiency virus type 1 inhibits DNA damage-triggered apoptosis by a Nef-independent mechanism. J Virol. 2005;79(9):5489\u201398.", "ArticleIdList": ["PMC1082752", "15827163"]}, {"Citation": "Song Y, Wang Y, Wang Z. Requirement for etoposide in the initial treatment of Epstein-Barr virus\u2013associated haemophagocytic lymphohistiocytosis. Br J Haematol. 2019;186(5):717\u201323.", "ArticleIdList": ["31115044"]}, {"Citation": "Volcy K, Fraser NW. DNA damage promotes herpes simplex virus-1 protein expression in a neuroblastoma cell line. J Neurovirol. 2013;19(1):57\u201364.", "ArticleIdList": ["PMC3572510", "23354549"]}, {"Citation": "Chen YW, Yiu C-PB, Wong KY. Prediction of the SARS-CoV-2 (2019-nCoV) 3C-like protease (3CLpro) structure: virtual screening reveals velpatasvir, ledipasvir, and other drug repurposing candidates. F1000 Res. 2020;9:129.", "ArticleIdList": ["PMC7062204", "32194944"]}, {"Citation": "Stuart MC, Kouimtzi M, Hill SR, editors. WHO model formulary 2008. World Health Organization; 2009."}, {"Citation": "Deftereos SG, Siasos G, Giannopoulos G, Vrachatis DA, Angelidis C, Giotaki SG, et al. The Greek study in the Effects of Colchicine in COvid-19 complications prevention (GRECCO-19 study): rationale and study design. Hell J Cardiol. 2020", "ArticleIdList": ["PMC7194546", "32251729"]}, {"Citation": "Drugs and Lactation Database (LactMed) Bethesda (MD): National Library of Medicine (US); 2006. Colchicine."}, {"Citation": "Tursen U, T\u00fcrsen B, Lotti T. Coronavirus-days in dermatology. Dermol Ther. 2020", "ArticleIdList": ["PMC7235478", "32307810"]}, {"Citation": "US National Library of Medicine. Colchicine coronavirus SARS-CoV 2 trial (COLCORONA) (COVID-19)  \n https://clinicaltrials.gov/ct2/show/NCT04322682\n."}, {"Citation": "Gultekin N, Kucukates E. Microtubule inhibition therapy by colchicine in severe myocarditis especially caused by Epstein-Barr and cytomegalovirus co-infection during a two-year period: a novel therapeutic approach. J Pak Med Assoc. 2014;64:1420\u20133.", "ArticleIdList": ["25842592"]}, {"Citation": "Redel H. Open forum infectious diseases. 2. Vol. 3. Oxford University Press; 2016. A case of chikungunya virus induced arthralgia responsive to colchicine; p. w114.", "ArticleIdList": ["PMC4943530", "27419183"]}, {"Citation": "Deftereos S, Giannopoulos G, Papoutsidakis N, Panagopoulou V, Kossyvakis C, Raisakis K, et al. Colchicine and the heart: pushing the envelope. J Am Coll Cardiol. 2013;62(20):1817\u201325.", "ArticleIdList": ["24036026"]}, {"Citation": "Imazio M, Brucato A, Ferrazzi P, Pullara A, Adler Y, Barosi A, et al. Colchicine for prevention of post-pericardiotomy syndrome and postoperative atrial fibrillation: the COPPS-2 randomized clinical trial. Jama. 2014;312(10):1016\u201323.", "ArticleIdList": ["25172965"]}, {"Citation": "Imazio M, Bobbio M, Cecchi E, Demarie D, Demichelis B, Pomari F, et al. Colchicine in addition to conventional therapy for acute pericarditis: results of the Colchicine for acute PEricarditis (COPE) trial. Circulation. 2005;112(13):2012\u20136.", "ArticleIdList": ["16186437"]}, {"Citation": "Imazio M, Brucato A, Cemin R, Ferrua S, Maggiolini S, Beqaraj F, et al. A randomized trial of colchicine for acute pericarditis. N Engl J Med. 2013;369(16):1522\u20138.", "ArticleIdList": ["23992557"]}, {"Citation": "Watanabe T, Kawakami E, Shoemaker JE, Lopes TJ, Matsuoka Y, Tomita Y, et al. Influenza virus-host inter-actome screen as a platform for antiviral drug development. Cell Host Microbe. 2014;16(6):795\u2013805.", "ArticleIdList": ["PMC4451456", "25464832"]}, {"Citation": "Slobodnick A, Shah B, Pillinger MH, Krasnokutsky S. Colchicine: old and new. Am J Med. 2015;128(5):461\u201370.", "ArticleIdList": ["PMC4684410", "25554368"]}, {"Citation": "G\u00fcrkan A, Oguz MM, Cengiz EB, Senel S. Dermatologic manifestations of colchicine intoxication. Pediatr Emerg Care. 2018;34(7):e131\u20133.", "ArticleIdList": ["29912088"]}, {"Citation": "Neil MJ. The Merck Index: an Encyclopedia of chemicals, drugs and biologicals. New Jersey: Whitehouse Station; 2006. Published by Merck Research Laboratories, Division of Merck and Co."}, {"Citation": "Jasek W. Austria-Codexvol. 1. Vienna: \u00d6sterreichischer Apothekerverlag; 2007. pp. 1731\u20134."}, {"Citation": "Tanoue LT, Detterbeck FC. Lung cancer: a practical approach to evidence-based clinical evaluation and management. Elsevier Health Sciences. 2018"}, {"Citation": "Yusenko M, Jakobs A, Klempnauer KH. A novel cell-based screening assay for small-molecule MYB inhibitors identifies podophyllotoxins teniposide and etoposide as inhibitors of MYB activity. Sci Rep. 2018;8(1):1\u201311.", "ArticleIdList": ["PMC6120916", "30177851"]}, {"Citation": "Richter A, Strausfeld U, Knippers R. Effects of VM26 (teniposide), a specific inhibitor of type II DNA topoisomerase, on SV40 DNA replication in vivo. Nucleic Acids Res. 1987;15(8):3455\u201368.", "ArticleIdList": ["PMC340741", "3033604"]}, {"Citation": "Aneja R, Liu M, Yates C, Gao J, Dong X, Zhou B, et al. Multidrug resistance-associated protein\u2013overexpressing teniposide-resistant human lymphomas undergo apoptosis by a tubulin-binding agent. Can Res. 2008;68:1495\u2013503.", "ArticleIdList": ["18316614"]}, {"Citation": "Silberstein LE, Anastasi J. Hematology: basic principles and practice E-book. Elsevier Health Sciences. 2017"}, {"Citation": "Attia AM, Bakrey OA, Abd El-Motaleb SMF. The use of podophyllotoxin for treatment of genital warts. Menoufia Med J. 2015;28:367."}, {"Citation": "Podofilox. The American Society of Health-System Pharmacists. Retrieved 8 December 2016."}, {"Citation": "Canel C, Moraes RM, Dayan FE, Ferreira D. Podophyllotoxin. Phytochemistry. 2000;54(2):115\u201320.", "ArticleIdList": ["10872202"]}, {"Citation": "Gordaliza M, Garc\u00f5a PA, Del Corral JM, Castro MA, G\u00f3mez-Zurita MA. Podophyllotoxin: distribution, sources, applications and new cytotoxic derivatives. Toxicon. 2004;44(4):441\u201359.", "ArticleIdList": ["15302526"]}, {"Citation": "Ardalani H, Avan A, Ghayour-Mobarhan M. Podophyllotoxin: a novel potential natural anticancer agent. Avicenna J Phytomed. 2017;7:285.", "ArticleIdList": ["PMC5580867", "28884079"]}, {"Citation": "McKee TC, Bokesch HR, McCormick JL, Rashid MA, Spielvogel D, Gustafson KR, et al. Isolation and characterization of new anti-HIV and cytotoxic leads from plants, marine, and microbial organisms. J Nat Prod. 1997;60(5):431\u20138.", "ArticleIdList": ["9170286"]}, {"Citation": "Sudo K, Konno K, Shigeta S, Yokota T. Inhibitory effects of podophyllotoxin derivatives on herpes simplex virus replication. Antivir Chem Chemother. 1998;9(3):263\u20137.", "ArticleIdList": ["9875405"]}, {"Citation": "Liu YQ, Tian X. Synthesis of novel spin-labeled derivatives of podophyllotoxin as potential antineoplastic agents. Synthetic Commun. 2005;35(21):2749\u201358.", "ArticleIdList": ["17691049"]}, {"Citation": "World Health Organization. 9789 241547659 WHO model formulary. :307."}, {"Citation": "Bukowski JA. Review of the epidemiological evidence relating toluene to reproductive outcomes. Regul Toxicol Pharmacol. 2001;33:147\u201356.", "ArticleIdList": ["11350197"]}, {"Citation": "Sundharam JA. Is podophyllin safe for use in pregnancy? Arch Dermatol. 1989;125(7):1000\u20131.", "ArticleIdList": ["2742385"]}, {"Citation": "Podophyllotoxin. DermNet New Zealand\u201d.   www.dermnetnz.orgRetrieved 2018-05-06."}, {"Citation": "Gan LS, Wang ZZ, Zhou CX. Solubility of podophyllotoxin in six organic solvents from (283.2 to 323.2) K. J Chem Eng Data. 2009;54(1):160\u20131."}, {"Citation": "Li H, Li Q, Liu Z, Yang K, Chen Z, Cheng Q, et al. The versatile effects of dihydromyricetin in health. Evid-Based Compl Alt. 2017:2017.", "ArticleIdList": ["PMC5602609", "28947908"]}, {"Citation": "Murakami T, Miyakoshi M, Araho D, Mizutani K, Kambara T, Ikeda T, et al. Hepatoprotective activity of tocha, the stems and leaves of Ampelopsis grossedentata, and ampelopsin. Biofactors. 2004;21(1\u20134):175\u20138.", "ArticleIdList": ["15630194"]}, {"Citation": "Kou X, Liu X, Chen X, Li J, Yang X, Fan J, et al. Ampelopsin attenuates brain aging of D-gal-induced rats through miR-34a-mediated SIRT1/mTOR signal pathway. Oncotarget. 2016;7(46):74484.", "ArticleIdList": ["PMC5342681", "27780933"]}, {"Citation": "Mart\u00ednez-Coria H, Mendoza-Rojas MX, Arrieta-Cruz I, L\u00f3pez-Vald\u00e9es HE. Preclinical research of Dihydromyricetin for brain aging and neurodegenerative diseases. Front Parmacol. 2019;10:1334.", "ArticleIdList": ["PMC6859532", "31780947"]}, {"Citation": "Chen S, Zhao X, Wan J, Ran Li, Yu Qin, Wang X, et al. Dihydromyricetin improves glucose and lipid metabolism and exerts anti-inflammatory effects in nonalcoholic fatty liver disease: a randomized controlled trial. Pharmacol Res. 2015;99:74\u201381.", "ArticleIdList": ["26032587"]}, {"Citation": "Ye XL, Lu LQ, Li W, Lou Q, Guo HG, Shi QJ. Oral administration of ampelopsin protects against acute brain injury in rats following focal cerebral ischemia. Exp Ther Med. 2017;13(5):1725\u201334.", "ArticleIdList": ["PMC5443315", "28565759"]}, {"Citation": "Zhou Y, Shu F, Liang X, Chang H, Shi L, Peng X, et al. Ampelopsin induces cell growth inhibition and apoptosis in breast cancer cells through ROS generation and endoplasmic reticulum stress pathway. PloS one. 2014;9(2)", "ArticleIdList": ["PMC3923868", "24551210"]}, {"Citation": "\n\nCN102772398A. \nApplication of dihydromyricetin in preparation of drug preventing and treating influenza. \n\nChinese patent No.  \n https://patents.google.com/patent/CN102772398A/en\n."}, {"Citation": "CN108354923. Applications of dihydromyricetin in preparation of anti-influenza virus drugs. Chinese patent No."}, {"Citation": "Zhang P, Cai S, Song L, Zhang L, Fan H, Zhou L, et al. Solubility of dihydromyricetin in ethanol and water mixtures from 288.15 to 323.15 K. J Mol Liq. 2015;211:197\u2013202."}, {"Citation": "Zhang S, Li H, Yang SJ. Tribulosin protects rat hearts from ischemia/reperfusion injury. Acta Pharmacol Sin. 2010;31:671\u20138.", "ArticleIdList": ["PMC4002968", "20453871"]}, {"Citation": "Zhang S, Li H, Yang SJ. Tribulosin suppresses apoptosis via PKC epsilon and ERK1/2 signaling pathway during hypoxia/ reoxygenation in neonatal rat ventricular cardiac myocytes. J Asian Nat Prod Res. 2011;13(12):209\u201320.", "ArticleIdList": ["22115037"]}, {"Citation": "Sharifi AM, Darabi R, Akbarloo N. Study of antihypertensive mechanism of Tribulus terrestris in 2K1C hypertensive rats: role of tissue ACE activity. Life Sci. 2003;73(23):2963\u201371.", "ArticleIdList": ["14519445"]}, {"Citation": "Zhu W, Du Y, Meng H, Dong Y, Li L. A review of traditional pharmacological uses, phytochemistry, and pharmacological activities of Tribulus terrestris. Chem Cent J. 2017;11:60.", "ArticleIdList": ["PMC5503856", "29086839"]}, {"Citation": "Rogerson S, Riches CJ, Jennings C, Weatherby RP, Meir RA, Marshall-Gradisnik SM. The effect of five weeks of Tribulus terrestris supplementation on muscle strength and body composition during preseason training in elite rugby league players. J Strength Cond Res. 2007;21:348\u201353.", "ArticleIdList": ["17530942"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "11", "Day": "9"}, {"Year": "2021", "Month": "8", "Day": "26"}, {"Year": "2022", "Month": "6", "Day": "1", "Hour": "15", "Minute": "13"}, {"Year": "2022", "Month": "6", "Day": "2", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "6", "Day": "7", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "12", "Day": "15"}], "PublicationStatus": "epublish", "ArticleIdList": ["35649148", "PMC9931022", "10.38212/2224-6614.3380", "2224-6614.3380"]}}], "PubmedBookArticle": []}